Biocon Shares Surge 5.5% After USFDA Approval of Biosimilar Cancer Drug JOBEVNE

Biocon Shares Surge 5.5% After USFDA Approval of…

ByAbhinandanApr 11, 2025

On April 11, Biocon’s share price surged 5.5% after its…

JOIN US
Image Not Found

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!